Table 2.
Response to treatment (pre-pubertal) given as mean (SD) or median (min–max).
| Patients (40) | Group A (17) | Group B (13) | Group C (10) | Sign | n | |
|---|---|---|---|---|---|---|
| AH (cm) | 163.4 (9.5) | 166.2 (9.7) | 161.6 (9.8) | 160.9 (8.3) | P = 0.28 | 40 |
| AH (SDS) | −1.22 (0.93) | −0.89 (0.99) | −1.54 (0.95) | −1.38 (0.66) | P = 0.14 | 40 |
| MPH (SDS) | −0.81 (0.87) | −0.77 (1.0) | −0.73 (0.79) | −0.99 (0.80) | P = 0.77 | 37 |
| ΔHT at AH (SDS) | 1.37 (1.0) | 1.95 (−0.39 to 3.79) | 1 (− 0.41 to 2.9) | 1.34 (0.51–1.7) | P = 0.08 | 36 |
| AH-MPH (SDS) | −0.41 (1.15) | −0.05 (−3.01 to 1.42) | −0.5 (−2.73 to 0.77) | −0.24 (−1.95 to 1.87) | P = 0.23 | 37 |
| Dose AH (mg/kg/day) | 0.026 (0.099) | 0.03 (0.011) | 0.022 (0.008) | 0.022 (0.006) | P = 0.07 | 32 |
AH adult height, MPH mid-parental height, HT height.